Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
covid-19_therapeutics_task_force [2023/04/29 07:43] liam [Members] | covid-19_therapeutics_task_force [2023/04/30 06:47] (current) liam [History] |
---|
The **COVID-19 Therapeutics Task Force** was a Canadian public-private advisory body convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force)) | The **COVID-19 Therapeutics Task Force** was a Canadian public-private advisory body convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force)) |
| |
| ===== History ===== |
| |
| [[Navdeep Bains]], Minister of Innovation, Science and Industry, announced the membership of the COVID-19 Therapeutics Task Force on August 5, 2020.((Jagric, A., Roy, C., Innovation, Science and Economic Development Canada, & Public Services and Procurement Canada. (2020, August 5). //Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies.// Government of Canada. http://archive.today/2022.12.16-235932/https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html)) Bains also announced the membership of the [[COVID-19 Vaccine Task Force]]. |
===== Members ===== | ===== Members ===== |
| |
| [[Ali Tehrani]] | Member | [[pharmaceutical_companies:Zymeworks]], [[Student Biotechnology Network]] (SBN), [[Consortium de recherche biopharmaceutique]] (CQDM), [[Life Sciences British Columbia]], [[Mitacs]], [[BIOTECanada]], [[Premier's Technology Council]], [[pharmaceutical_companies:Creatus Biosciences]] | | | [[Ali Tehrani]] | Member | [[pharmaceutical_companies:Zymeworks]], [[Student Biotechnology Network]] (SBN), [[Consortium de recherche biopharmaceutique]] (CQDM), [[Life Sciences British Columbia]], [[Mitacs]], [[BIOTECanada]], [[Premier's Technology Council]], [[pharmaceutical_companies:Creatus Biosciences]] | |
| [[Youla Tsantrizos]] | Member | [[McGill University]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Centre de recherche en biologie structurale]] (CRBS), [[Canadian Society for Chemistry]], [[Natural Sciences and Engineering Research Council of Canada]] (NSERC), [[Canadian Institutes of Health Research]] (CIHR), [[Ontario Institute for Cancer Research]] (OICR) | | | [[Youla Tsantrizos]] | Member | [[McGill University]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Centre de recherche en biologie structurale]] (CRBS), [[Canadian Society for Chemistry]], [[Natural Sciences and Engineering Research Council of Canada]] (NSERC), [[Canadian Institutes of Health Research]] (CIHR), [[Ontario Institute for Cancer Research]] (OICR) | |
| ^ Advisors ^^^ |
| | [[Lisa Barrett]] | Advisor | [[Dalhousie University]], [[Senescence Aging Infection & Immunity Lab]] (SAIL), [[National Institute of Allergy and Infectious Diseases]] (NIAID) | |
| | [[Marceline Côté]] | Advisor | [[University of Ottawa]] | |
| | [[Eleanor Fish]] | Advisor | [[University of Toronto]], [[University Health Network]] (UHN) | |
| | [[Matthias Götte]] | Advisor | [[Li Ka Shing Institute of Virology]], [[McGill University]] | |
| | [[François Jean]] | Advisor | [[Facility for Infectious Disease and Epidemic Research]] (FINDER) | |
| | [[Samira Mubareka]] | Advisor | [[Sunnybrook Health Sciences Centre]], [[University of Toronto]], [[Centre for Research Expertise in Occupational Disease]] (CREOD), [[Canadian COVID-19 Genomics Network]] (CanCOGen), [[Genome Canada]], [[Ontario's COVID-19 Genomics Rapid Response Coalition]] (ONCoV), [[Ontario Academic Health Sciences SARS-CoV-2 Sequencing Network]] (ONS2), [[Sunnybrook Translational Research Group for Emerging Respiratory Viruses]] (SERV) | |
| | [[Pamela Ohashi]] | Advisor | [[Princess Margaret Cancer Centre]], [[University of Toronto]], [[American Association for Cancer Research]] (AACR), [[Society for Immunotherapy of Cancer]] (SITC), [[Royal Society of Canada]] (RSC) | |
| | [[James Russell]] | Advisor | [[University of British Columbia]] (UBC), [[Centre for Heart Lung Innovation]] (HLI), [[Sirius Genomics]], [[pharmaceutical_companies:Cyon Therapeutics]], [[St. Paul's Hospital]] | |
| | [[Makeda Semret]] | Advisor | [[McGill University Health Centre]] (MUHC), [[Joint Programming Initiative on Antimicrobial Resistance]] (JPIAMR), [[AAU-McGill Partnership for Infectious Diseases]] (AMP-ID) | |
| | [[Don Sheppard]] | Advisor | [[McGill University Health Centre]] (MUHC), [[McGill Interdisciplinary Initiative in Infection and Immunity]] (MI4) | |
| | [[Don Vinh]] | Advisor | [[McGill University Health Centre]] (MUHC), [[Canadian Glycomics Network]] (GlycoNet), [[Association of Medical Microbiology and Infectious Disease Canada]] (AMMI), [[Clinical Immunology Society]] (CIS), [[Comité consultatif québécois pour les maladies rares]], [[MUHC COVID-19 Biobank]], [[COVID-19 and Cancer Consortium]] (CCC19), [[COVID Human Genetic Effort]] (CHGE) | |
| |
| ===== External links ===== |
| |
| * [[http://covidtruthinitiative.ca/Organizations/COVID-19-Therapeutics-Task-Force|COVID Truth Initiative]] |